November 5, 2021 -- InvestorsHub NewsWire -- via pennymillions -- 

AmericanBulls

Pharmagreen Biotech, Inc. (PHBI) is reported today by AmericnaBulls (americanbulls.com/PHBI) to be signaling BUY



Our system’s recommendation today is to BUY. The BULLISH HARAMI CROSS pattern finally received a confirmation because the prices crossed above the confirmation level which was at 0.0240, and our valid average buying price stands now at 0.0242. 

The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated. The market is telling you about a new profit. Do not miss this bullish opportunity.

PHBI, a cannabis industry proprietary technology company, yesterday published news on its anticiapted OTCQA uplisting:

Pharmagreen Submits Its Application for Uplisting to the OTCQB Venture Market

Source - americanbulls.com/PHBI

Other cannabis sector stocks in the news include PURA, MJNA, and PAOG.

 

SOURCE: pennymillions

Grafico Azioni Pharmagreen Biotech (PK) (USOTC:PHBI)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di Pharmagreen Biotech (PK)
Grafico Azioni Pharmagreen Biotech (PK) (USOTC:PHBI)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di Pharmagreen Biotech (PK)